Delayed esophageal perforation from stereotactic body radiation therapy for locally recurrent central nonsmall cell lung cancer

Sandeep Sainathan, Leester D. Wu, Shahriyour Andaz

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Stereotactic body radiation therapy (SBRT) is a novel form of external beam radiation therapy. It is used to treat early and locally recurrent nonsmall cell lung cancer (NSLC) in medically inoperable patients. It uses high dose, hypofractionated radiotherapy, with targeting of the tumor by precise spatial localization, thus minimizing injury to surrounding tissues. It can be safely used to ablate NSLC in both central and peripheral locations. We present two cases of delayed esophageal perforation after SBRT for locally recurrent central NSLC. The perforations occurred several months after the therapy. They were treated with covered esophageal stents, with mortality, due to the perforation in one of the patients. SBRT should be judiciously used to ablate centrally located NSLC and patients who develop episodes of esophagitis during or after SBRT, need to be closely followed with endoscopy to look for esophageal ulcerations. These ulcers should be closely followed for healing as these may degenerate into full thickness perforations several months after SBRT.

Original languageEnglish (US)
Pages (from-to)158-160
Number of pages3
JournalLung India
Volume31
Issue number2
DOIs
StatePublished - Jan 1 2014

Fingerprint

Esophageal Perforation
Non-Small Cell Lung Carcinoma
Radiotherapy
Esophagitis
Endoscopy
Ulcer
Stents
Mortality
Wounds and Injuries

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine

Cite this

Delayed esophageal perforation from stereotactic body radiation therapy for locally recurrent central nonsmall cell lung cancer. / Sainathan, Sandeep; Wu, Leester D.; Andaz, Shahriyour.

In: Lung India, Vol. 31, No. 2, 01.01.2014, p. 158-160.

Research output: Contribution to journalArticle

@article{ed8a74e7922e4010b578acaa66e08bed,
title = "Delayed esophageal perforation from stereotactic body radiation therapy for locally recurrent central nonsmall cell lung cancer",
abstract = "Stereotactic body radiation therapy (SBRT) is a novel form of external beam radiation therapy. It is used to treat early and locally recurrent nonsmall cell lung cancer (NSLC) in medically inoperable patients. It uses high dose, hypofractionated radiotherapy, with targeting of the tumor by precise spatial localization, thus minimizing injury to surrounding tissues. It can be safely used to ablate NSLC in both central and peripheral locations. We present two cases of delayed esophageal perforation after SBRT for locally recurrent central NSLC. The perforations occurred several months after the therapy. They were treated with covered esophageal stents, with mortality, due to the perforation in one of the patients. SBRT should be judiciously used to ablate centrally located NSLC and patients who develop episodes of esophagitis during or after SBRT, need to be closely followed with endoscopy to look for esophageal ulcerations. These ulcers should be closely followed for healing as these may degenerate into full thickness perforations several months after SBRT.",
author = "Sandeep Sainathan and Wu, {Leester D.} and Shahriyour Andaz",
year = "2014",
month = "1",
day = "1",
doi = "10.4103/0970-2113.129854",
language = "English (US)",
volume = "31",
pages = "158--160",
journal = "Lung India",
issn = "0970-2113",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "2",

}

TY - JOUR

T1 - Delayed esophageal perforation from stereotactic body radiation therapy for locally recurrent central nonsmall cell lung cancer

AU - Sainathan, Sandeep

AU - Wu, Leester D.

AU - Andaz, Shahriyour

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Stereotactic body radiation therapy (SBRT) is a novel form of external beam radiation therapy. It is used to treat early and locally recurrent nonsmall cell lung cancer (NSLC) in medically inoperable patients. It uses high dose, hypofractionated radiotherapy, with targeting of the tumor by precise spatial localization, thus minimizing injury to surrounding tissues. It can be safely used to ablate NSLC in both central and peripheral locations. We present two cases of delayed esophageal perforation after SBRT for locally recurrent central NSLC. The perforations occurred several months after the therapy. They were treated with covered esophageal stents, with mortality, due to the perforation in one of the patients. SBRT should be judiciously used to ablate centrally located NSLC and patients who develop episodes of esophagitis during or after SBRT, need to be closely followed with endoscopy to look for esophageal ulcerations. These ulcers should be closely followed for healing as these may degenerate into full thickness perforations several months after SBRT.

AB - Stereotactic body radiation therapy (SBRT) is a novel form of external beam radiation therapy. It is used to treat early and locally recurrent nonsmall cell lung cancer (NSLC) in medically inoperable patients. It uses high dose, hypofractionated radiotherapy, with targeting of the tumor by precise spatial localization, thus minimizing injury to surrounding tissues. It can be safely used to ablate NSLC in both central and peripheral locations. We present two cases of delayed esophageal perforation after SBRT for locally recurrent central NSLC. The perforations occurred several months after the therapy. They were treated with covered esophageal stents, with mortality, due to the perforation in one of the patients. SBRT should be judiciously used to ablate centrally located NSLC and patients who develop episodes of esophagitis during or after SBRT, need to be closely followed with endoscopy to look for esophageal ulcerations. These ulcers should be closely followed for healing as these may degenerate into full thickness perforations several months after SBRT.

UR - http://www.scopus.com/inward/record.url?scp=84940247046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940247046&partnerID=8YFLogxK

U2 - 10.4103/0970-2113.129854

DO - 10.4103/0970-2113.129854

M3 - Article

VL - 31

SP - 158

EP - 160

JO - Lung India

JF - Lung India

SN - 0970-2113

IS - 2

ER -